N-Salicyloyltryptamine

N-Salicyloyltryptamine 是一种电压依赖性离子通道抑制剂,可作用于 Na+、Ca2+ 和 K+ 通道,其抑制 K+ 电流(Ito)的 IC50 为 34.6 μM,并具有抗惊厥、抗炎、镇痛和血管舒张作用。
产品编号: MS-X39138 纯度: 96.37% CAS No.: 31384-98-2 分子式: C17H16N2O2 分子量: 280.32
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
5mg
询价
3-5 天
10mg
询价
3-5 天
50mg
询价
询价
100mg
询价
询价

产品描述

N-Salicyloyltryptamine 是一种电压依赖性离子通道抑制剂,可作用于 Na+、Ca2+ 和 K+ 通道,其抑制 K+ 电流(Ito)的 IC50 为 34.6 μM,并具有抗惊厥、抗炎、镇痛和血管舒张作用。

生物实验数据

生物活性 N-Salicyloyltryptamine is a voltage-dependent ion channel inhibitor that acts on Na+, Ca2+, and K+ channels, inhibits K+ current (Ito) with an IC50 of 34.6 μM, and also exhibits anticonvulsant, anti-inflammatory, analgesic, and vasodilatory effects.
IC50 & Target K+ channel:34.6 μM
体外研究
(In Vitro)

N-Salicyloyltryptamine (1 ng/mL-1 μg/mL; 24 h) presents no cytotoxicity and causes no oxidative stress in RAW 264.7 cells at low concentration, but (50 and 100 μg/mL) inhibits cell viability with an IC50 value of 22.75 μg/mL.
N-Salicyloyltryptamine (1 μg/mL; 24 h) reverses some redox and inflammatory parameters induced by LPS without interfering in cell viability.
N-Salicyloyltryptamine (1 μg/mL; 24 h) inhibits LPS-induced TNF-α and IL-1β release, as well as CD40 and TNF-α protein up-regulation.
N-Salicyloyltryptamine (1 μg/mL; 24 h) inhibits phosphorylation of ERK 1/2 and IκBα and p65 nuclear translocation (NF-kB activation).
N-Salicyloyltryptamine (17 μM) inhibits K+ current by 59.27% (Ito) and 73.18% (IKD), inhibits L-type Ca2+ currents by 54.9%, and shows few inhibition with high concentration (170 μM) on TTX-sensitive Na+ current by 22.1% in GH3 cells.
N-Salicyloyltryptamine (0.01 nM-100 µM) produces vasorelaxation through activation of the NO/sGC/cGMP pathway and reduction of calcium influx.

Cell Viability Assay

Cell Line: RAW 264.7 cell
Concentration: 0.001, 0.05, 1, 50, 100 μg/mL
Incubation Time: 24 hours
Result: Resulted no effect on RAW 264.7 cell viability at 1 μg/mL; however, concentrations of 50 and 100 μg/mL significantly decreased both MTT reduction and SRB incorporation.

RT-PCR

Cell Line: RAW 264.7 cell
Concentration: 1 μg/mL
Incubation Time: 24 hours
Result: Reduced CD40, TNF-α, and RAGE immunocontent.
Inhibited ERK1/2 and IκBα phosphorylation and nuclear translocation of p65.
体内研究
(In Vivo)

N-Salicyloyltryptamine (100 mg/kg; i.p.; 60 min before stimulation challenge) significantly inhibits pentylenetetrazol (PTZ)-induced seizures and partially eliminates the extensor reflex of maximal electric-induced seizures test.
N-Salicyloyltryptamine (100 mg/kg, 200 mg/kg; i.p.; single dose) shows antinociceptive and nerve excitability effects.

Animal Model: Male Swiss mice (25-35 g)
Dosage: 50, 100, 200 mg/kg
Administration: Intraperitoneal injection; single dose; 60 min before stimulation challenge
Result: Reduced the incidence of clonic pentylenetetrazol (PTZ) seizures and mortality at 50 mg/kg, and decreased the incidence of tonic hindlimb extension (THE) produced by MES at 100, 200 mg/kg.
Animal Model: Male Swiss mice (25-35 g)
Dosage: 100 mg/kg; 200 mg/kg
Administration: Intraperitoneal injection; single dose
Result: Reduced the acetic acid-induced licking response of the injected paw.
性状 固体
颜色 Off-white to light brown

化学信息

分子量 280.32
分子式 C17H16N2O2
CAS No. 31384-98-2

储存&溶解度

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMSO 中的溶解度 : 125 mg/mL (445.92 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

可选溶剂浓度1 mg5 mg10 mg25 mg
DMSO1 mM3.5674 mL17.8368 mL35.6735 mL89.1838 mL
5 mM0.7135 mL3.5674 mL7.1347 mL17.8368 mL
10 mM0.3567 mL1.7837 mL3.5674 mL8.9184 mL
15 mM0.2378 mL1.1891 mL2.3782 mL5.9456 mL
20 mM0.1784 mL0.8918 mL1.7837 mL4.4592 mL
25 mM0.1427 mL0.7135 mL1.4269 mL3.5674 mL
30 mM0.1189 mL0.5946 mL1.1891 mL2.9728 mL
40 mM0.0892 mL0.4459 mL0.8918 mL2.2296 mL
50 mM0.0713 mL0.3567 mL0.7135 mL1.7837 mL
60 mM0.0595 mL0.2973 mL0.5946 mL1.4864 mL
80 mM0.0446 mL0.2230 mL0.4459 mL1.1148 mL
100 mM0.0357 mL0.1784 mL0.3567 mL0.8918 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础